TRIESTE, LEOPOLDO
 Distribuzione geografica
Continente #
NA - Nord America 8.645
EU - Europa 5.860
AS - Asia 4.666
SA - Sud America 899
Continente sconosciuto - Info sul continente non disponibili 139
AF - Africa 125
OC - Oceania 43
Totale 20.377
Nazione #
US - Stati Uniti d'America 8.263
IT - Italia 2.054
SG - Singapore 1.715
RU - Federazione Russa 1.195
CN - Cina 1.146
GB - Regno Unito 737
BR - Brasile 690
VN - Vietnam 632
DE - Germania 444
UA - Ucraina 286
CA - Canada 263
HK - Hong Kong 235
BD - Bangladesh 218
FR - Francia 190
SE - Svezia 164
KR - Corea 163
DK - Danimarca 148
IN - India 138
NL - Olanda 119
FI - Finlandia 95
PL - Polonia 83
AR - Argentina 79
IE - Irlanda 75
MX - Messico 63
ES - Italia 61
JP - Giappone 58
TR - Turchia 56
ZA - Sudafrica 48
ID - Indonesia 47
EC - Ecuador 42
AU - Australia 38
BE - Belgio 34
PH - Filippine 34
IQ - Iraq 32
AT - Austria 30
PK - Pakistan 30
CO - Colombia 26
MY - Malesia 26
PT - Portogallo 24
CH - Svizzera 21
EU - Europa 20
IL - Israele 20
TW - Taiwan 19
LT - Lituania 15
TN - Tunisia 15
MA - Marocco 14
PY - Paraguay 14
RO - Romania 14
VE - Venezuela 13
SA - Arabia Saudita 12
SK - Slovacchia (Repubblica Slovacca) 12
UZ - Uzbekistan 12
CL - Cile 11
JO - Giordania 11
PE - Perù 11
JM - Giamaica 10
KE - Kenya 9
CR - Costa Rica 8
AZ - Azerbaigian 7
HN - Honduras 7
SN - Senegal 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
CZ - Repubblica Ceca 6
EG - Egitto 6
GR - Grecia 6
LV - Lettonia 6
NI - Nicaragua 6
SY - Repubblica araba siriana 6
UY - Uruguay 6
BY - Bielorussia 5
CY - Cipro 5
DO - Repubblica Dominicana 5
HU - Ungheria 5
IR - Iran 5
KZ - Kazakistan 5
LU - Lussemburgo 5
NP - Nepal 5
NZ - Nuova Zelanda 5
OM - Oman 5
TH - Thailandia 5
DZ - Algeria 4
SI - Slovenia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
AO - Angola 3
BO - Bolivia 3
DM - Dominica 3
GT - Guatemala 3
NG - Nigeria 3
PS - Palestinian Territory 3
SR - Suriname 3
UG - Uganda 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
ET - Etiopia 2
HR - Croazia 2
KG - Kirghizistan 2
LB - Libano 2
Totale 20.230
Città #
Dallas 1.867
Singapore 928
Ashburn 589
San Jose 587
Beijing 423
Chandler 375
Council Bluffs 370
Woodbridge 342
Southend 341
Houston 270
Milan 255
Pisa 221
Hong Kong 218
Rome 194
Moscow 185
San Mateo 175
Ho Chi Minh City 172
Los Angeles 171
Ann Arbor 170
The Dalles 156
New York 150
Jacksonville 142
Fairfield 123
Hanoi 123
Santa Clara 108
Dearborn 105
Seattle 102
Daejeon 97
Boardman 91
Cambridge 90
Wilmington 90
Falls Church 87
Phoenix 85
São Paulo 82
Hefei 77
Beauharnois 70
Lauterbourg 69
Dublin 67
Warsaw 67
Dong Ket 65
Seoul 62
Stevenage 61
Portsmouth 59
Buffalo 58
Montreal 57
Lawrence 55
Brooklyn 54
Orem 54
Florence 53
Fremont 49
Denver 48
London 43
Tokyo 43
Atlanta 42
Chennai 42
Munich 41
Bologna 38
Stockholm 38
Salerno 37
Figino 33
Helsinki 33
Chicago 32
Columbus 32
Johannesburg 31
Serra 31
Poplar 30
Mexico City 29
Frankfurt am Main 28
Haiphong 28
Naples 28
Paris 27
Turin 27
Genoa 26
Toronto 26
Buti 25
Montréal 25
Amsterdam 24
Lucca 23
Redwood City 23
Ankara 22
Old Bridge 21
Boston 20
Nuremberg 20
Ottawa 20
Rio de Janeiro 20
San Francisco 18
Mumbai 17
Trento 17
Da Nang 16
Quito 16
Charlotte 15
Dhaka 15
Guayaquil 15
Livorno 15
Querétaro 15
Vienna 15
Hamburg 14
Istanbul 14
Manchester 14
Tel Aviv 14
Totale 11.747
Nome #
Nutri-Score and Food Perception: Insights from an Italian Study 814
On Robots and Insurance 586
The Effect of using Serifs in Brand Names on Luxury Perception 564
Food literacy and food choice – a survey-based psychometric profiling of consumer behaviour 529
The Evaluative, Economic, and Organizational Dimensions of Personalized Medicine 430
The strength of Nutriscore in improving sustainable eating habits and well-being: bad and good news 410
Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study 395
An In Silico Health Economic Model Applied to Cryopyrin Associated Periodic Syndromes (Caps): Cost Effectiveness of Prevention Effects of Ultra-Orphan Drugs for Rare Diseases 378
How colour saturation accelerates purchase behaviour, and influences food choice: 348
Cost-effectiveness analysis and prevention effects of ultra-orphan drugs for rare diseases: an in silico model applied to Cryopyrin Associated Periodic Syndromes (CAPS) 342
A systematic literature review of the economic impact of ankylosing spondylitis 331
Is EEG Suitable for Marketing Research? A Systematic Review 315
Rare diseases under different levels of economic analysis: current activities, challenges and perspectives 309
Why effectiveness of robot-mediated neuro-rehabilitation does not necessarily influence its adoption? 305
Different strategies for latent TB assessment in patients undergoing anti-TNF treatment: an economic model 304
How to design a business model for technology-driven innovations like robots. The case of Robot-Era 303
Comparison of generic, condition-specific and mapped health state utility values for pediatric asthma 302
Approaching 2014: Is Telemedicine Assessed from The Social Perspective? A Brief 2013 Systematic Review 294
Natural and man-made disasters: challenges and international perspectives for insurance 293
The cost-effectiveness of drug therapies to treat secondary hyperparathyroidism in renal failure: a focus on evidence regarding paricalcitol and cinacalcet 293
Development of an objective feedback score for the evaluation of drug and medical device manufacturers/distributors as an additional parameter to be considered in public procurement 291
Assessing the value of the use of diagnostic technology: trade offs for GPs 288
Columbus' egg and the engineer's effect in forecasting solutions adoption 280
Cost for Tuberculosis Care in Developed Countries: Which Data for an Economic Evaluation? 280
RarERN Path: a methodology towards the optimisation of patients’ care pathways in rare and complex diseases developed within the European Reference Networks 277
The cost-effectiveness of diagnostic cardiac imaging for stable coronary artery disease 276
Being a caregiver of a Behçet’s syndrome patient: challenges and perspectives during a complex journey 274
The influence of parental Dietary Behaviors, food literacy and chronotype on Children’s eating habits and psychometric factors 273
Are drug procurement procedure and award criteria in EU hospital setting standardized and do they take into account effective supply quality? 273
Health information technologies in systemic lupus erythematosus: focus on patient assessment 272
TABLET TOSCANA to Develop Innovative Organizational Models for Tele-Rehabilitation in Subjects with Congenital and Acquired Developmental Disabilities: A Wait-List Control Group Trial Protocol 271
WEB SURVEY AND FOCUS GROUPS EXPLORING KNOWLEDGE, NEEDS AND EXPECTATIONS AMONG SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS: PRELIMINARY RESULTS 269
Improving organisation to improve care: ERN ReCONNET organisational reference model for systemic sclerosis patients’ care pathway 266
Taste Your Consumer Audience. How Sensory Expertise Influences Food Choice 265
Which indicators for measuring the daily physical activity? An overview on the challenges and technology limits for Telehealth applications 263
Asessment And Simulation of Costs And QOL For Sublingual Immunotherapy In Paediatric Asthma Vs Placebo: Preliminary Data 257
Conseguenze cliniche ed economiche dello switch ai biosimilari dell’Infliximab nei pazienti reumatologici in Toscana 255
KNOWLEDGE, USE AND DESIDERATA ABOUT INFORMATION AND COMMUNICATION TECHNOLOGIES SYSTEMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS. PRELIMINARY RESULTS FROM THE INTEGRATE PILOT PROJECT 255
The RaDiCEA Project: cost of illness (COI) analysis applied to Cryopyrin Associated Periodic Syndromes (CAPS) 252
Cost analysis of technological vs. conventional upper limb rehabilitation for patients with neurological disorders: an Italian real-world data case study 248
Systemic vasculitis: how little we know about their societal and economic burden 246
Management and Treatment of Type 1 And 2 Diabetes: State of Art 242
Consideration on the Accuracy of Watch for Physical Activity Tracker 233
Raiders of Lost Value 232
The definition of a new organizational, technology-based, integrated home care model 230
The nature, causes, and effects of skepticism on technology diffusion 229
Razionale e strumenti della valutazione economica in sanità 228
P56 Early Health Technology Assessment to Guide Introduction of Novel Technology into the Market: The Vostars System Case Study 227
The economic impact of gout: a systematic literature review 225
Rehabilitation with and Without Robot and Allied Digital Technologies (RADTs) in Stroke Patients: A Study Protocol for a Multicentre Randomised Controlled Trial on the Effectiveness, Acceptability, Usability, and Economic-Organisational Sustainability of RADTs from Subacute to Chronic Phase (STROKEFIT4) 224
Switching from infliximab‐originator to infliximab‐biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 224
Food literacy and food purchase behaviour 219
The cost of illness of ultra-rare Cryopyrin Associated Periodic Syndromes (CAPS) in Italy: Preliminary results from the Radicea project 218
Natura e ruolo degli indicatori nella logistica farmaceutica 208
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy 205
L’evoluzione della distribuzione del farmaco e dell'erogazione dei servizi in farmacia 204
The organizational dimension in rare and complex diseases care management: an application of RarERN Path© methodology in ataxias, dystonia and phenylketonuria 191
Analysis and Synthesis in Information Processing and Knowledge Creation 188
Innovazione tecnologica, dinamica del contesto economico e logistica in sanità 186
Telemonitoring in Cystic Fibrosis: A 4-year Assessment and Simulation for the Next 6 Years 186
Farmaci per le patologie autoimmuni. Traiettorie di trattamento nell’artrite reumatoide 184
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 183
Valutazione dei risultati di una gara 179
Finanziamenti pubblici 176
EYE ON PACK. Visual search strategies in food choice 174
State of the art and future directions in assessing the quality of life in rare and complex connective tissue and musculoskeletal diseases 173
Le start up 169
Validation of algorithms for selecting rheumatoid arthritis patients in the Tuscan healthcare administrative databases 168
Strumenti per favorire gli investimenti e la competitività delle imprese 163
Propedeutica alle scienze Sperimentali. Introduzione al metodo scientifico e all'inferenza statistica. 162
Managing customization, brand consistency, and identity dynamic trade-offs: opportunities and chaos 161
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 159
Valutazione dell’attività di malattia nei periodi di interruzione del trattamento con farmaci biologici modificanti la malattia reumatica in pazienti con artrite reumatoide 153
Industria 4.0 e Digitalizzazione 131
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study 130
Nonlinear trade-offs in customer acquisition and retention 98
Validazione degli algoritmi di selezione dei pazienti reumatologici nei database amministrativi toscani e traiettorie di aderenza ai farmaci biologici modificanti la malattia nell’artrite reumatoide 69
null 63
Identifying needs in adult rehabilitation to support the clinical implementation of robotics and allied technologies: an Italian national survey 39
The Role of Digital Tools and Their Implementation Within Patient Care Pathways for Rare Brain Disorders: The Case of Phenylketonuria 37
null 13
Condorcet Cycles, Contextuality, and the Emergence of Quantum-like Collective States 9
Self-produced signs in decision-making and contextual correlations 9
Totale 20.377
Categoria #
all - tutte 90.872
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.872


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022552 0 0 0 50 9 15 96 159 56 70 31 66
2022/2023841 65 85 46 134 100 136 10 47 122 28 36 32
2023/2024465 43 18 61 22 18 62 51 38 7 26 29 90
2024/20253.729 66 86 245 184 272 264 565 871 307 171 467 231
2025/20269.638 504 1.192 1.623 1.203 1.001 594 1.003 405 503 560 391 659
2026/20271.230 256 303 494 177 0 0 0 0 0 0 0 0
Totale 20.377